Author's reply: the influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy

被引：0
|
作者：
Serri, Omar [1 ]
机构：
[1] Univ Montreal, Notre Dame Hosp, CHUM, Montreal, PQ H2L 4M1, Canada
来源：
CLINICAL ENDOCRINOLOGY | 2007年 / 67卷 / 01期
关键词：
D O I：
10.1111/j.1365-2265.2007.02839.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [1] The influences of hyperprolactinaemia and obesity on cardiovascular risk markers:: effects of cabergoline therapy
    Schmid, Christoph
    Braendle, Michael
    CLINICAL ENDOCRINOLOGY, 2006, 65 (06) : 827 - 828
  • [2] The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
    Serri, O
    Li, L
    Mamputu, JC
    Beauchamp, MC
    Maingrette, F
    Renier, G
    CLINICAL ENDOCRINOLOGY, 2006, 64 (04) : 366 - 370
  • [3] CRP may be superior to anthropometric markers of obesity - Author's reply - Obesity measures
    Nakamura, Yasuyuki
    CIRCULATION JOURNAL, 2007, 71 (08) : 1332 - 1333
  • [4] Obesity and schizophrenia - Author's reply
    Thakore, JH
    BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 489 - 489
  • [5] Childhood obesity -: Author's reply
    Frühbeck, G
    BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7246): : 1402 - 1403
  • [6] Author's Reply: Mean Platelet Volume and Cardiovascular Risk Factors
    Sansanayudh, Nakarin
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 : E16 - E17
  • [7] Smoking v obesity Author's reply
    Kamerow, Douglas B.
    BRITISH MEDICAL JOURNAL, 2010, 341
  • [8] Obesity and lung function - Author's reply
    Schachter, L
    THORAX, 2001, 56 (09) : 741 - 741
  • [9] Obesity in School Children - Author's Reply
    Shamim, Ahmar
    INDIAN PEDIATRICS, 2016, 53 (01) : 75 - 75
  • [10] HRT and cardiovascular disease Author's reply
    Stevenson, John C.
    OBSTETRICIAN & GYNAECOLOGIST, 2005, 7 (03): : 212 - 213
12345